Dan Gibson

12.4k total citations · 1 hit paper
144 papers, 10.3k citations indexed

About

Dan Gibson is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Dan Gibson has authored 144 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Oncology, 85 papers in Organic Chemistry and 41 papers in Molecular Biology. Recurrent topics in Dan Gibson's work include Metal complexes synthesis and properties (98 papers), Ferrocene Chemistry and Applications (49 papers) and DNA and Nucleic Acid Chemistry (21 papers). Dan Gibson is often cited by papers focused on Metal complexes synthesis and properties (98 papers), Ferrocene Chemistry and Applications (49 papers) and DNA and Nucleic Acid Chemistry (21 papers). Dan Gibson collaborates with scholars based in Israel, Czechia and United States. Dan Gibson's co-authors include Raphael Mechoulam, Aviva Breuer, Graeme Griffin, William A. Devane, Asher Mandelbaum, Lesley Stevenson, Roger G. Pertwee, Ezequiel Wexselblatt, Yousef Najajreh and Viktor Brabec and has published in prestigious journals such as Science, Chemical Reviews and Journal of the American Chemical Society.

In The Last Decade

Dan Gibson

141 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

1992 4.5k citations Dan Gibson et al. profile →

Peers

Countries citing papers authored by Dan Gibson

Since Specialization

Citations

This map shows the geographic impact of Dan Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Gibson more than expected).

Fields of papers citing papers by Dan Gibson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Gibson. The network helps show where Dan Gibson may publish in the future.

Co-authorship network of co-authors of Dan Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Gibson. A scholar is included among the top collaborators of Dan Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Gibson. Dan Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Hana Kostrhunová, (unknown), Lenka Marková, Vojtěch Novohradský, Dan Gibson, Viktor Brabec	0
2	Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs 2025 ·Chemical Reviews ·(unknown), (unknown), (unknown), Xinyi Wang, Wei Heng Chng, (unknown), Kevin Tay, Lih‐Wen Deng, Dan Gibson, Hélène Bertrand, Giulia Adriani, Wee Han Ang, Giorgia Pastorin	1
3	Fluorescence‐Guided Spatial Drug Screening in 3D Colorectal Cancer Spheroids 2024 ·Advanced Healthcare Materials ·(unknown), Thirumal Yempala, (unknown), Giulio Giustarini, (unknown), Wee Han Ang, Dan Gibson, Giulia Adriani, Giorgia Pastorin	4
4	Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death 2023 ·Angewandte Chemie International Edition ·Amrita Sarkar, Vojtěch Novohradský, (unknown), (unknown), Lenka Marková, Hana Kostrhunová, Jana Kašpárková, Valentina Gandin, Viktor Brabec, Dan Gibson	33
5	Oral Anticancer Heterobimetallic Pt^IV−Au^IComplexes Show High In Vivo Activity and Low Toxicity 2023 ·Angewandte Chemie ·(unknown), (unknown), Uttara Basu, Hemma Schueffl, Sarah Theiner, Petra Heffeter, Gunda Koellensperger, Norman Metanis, Valentina Gandin, Ingo Ott, Claudia Schmidt, Dan Gibson	4
6	Study of the DNA binding mechanism and in vitro activity against cancer cells of iron(iii) and aluminium(iii) kojic acid derivative complexes 2022 ·Dalton Transactions ·Joanna Izabela Lachowicz, Anna Mateddu, Pierpaolo Coni, Claudia Caltagirone, Sergio Murgia, Dan Gibson, (unknown), Xabier López, Federico Meloni, Giuseppina Pichiri	2
7	Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity 2019 ·Angewandte Chemie International Edition ·Maria V. Babak, Zhi Yang, Bertrand Czarny, Tan Boon Toh, Lissa Hooi, Edward Kai‐Hua Chow, Wee Han Ang, Dan Gibson, Giorgia Pastorin	95
8	Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity 2019 ·Angewandte Chemie ·Maria V. Babak, Zhi Yang, Bertrand Czarny, Tan Boon Toh, Lissa Hooi, Edward Kai‐Hua Chow, Wee Han Ang, Dan Gibson, Giorgia Pastorin	27
9	Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates 2017 ·Scientific Reports ·Vojtěch Novohradský, Ilaria Zanellato, Cristina Marzano, Jitka Prachařová, Jana Kašpárková, Dan Gibson, Valentina Gandin, Domenico Osella, Viktor Brabec	35
10	Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin 2015 ·Journal of Inorganic Biochemistry ·Juraj Zajac, Hana Kostrhunová, Vojtěch Novohradský, Oldřich Vrána, Raji Raveendran, Dan Gibson, Jana Kašpárková, Viktor Brabec	55
11	In vivo biodistribution of platinum-based drugs encapsulated into multi-walled carbon nanotubes 2014 ·Nanomedicine Nanotechnology Biology and Medicine ·Jian Li, Aakanksha Pant, Chee Fei Chin, Wee Han Ang, Cécilia Ménard‐Moyon, Tapas R. Nayak, Dan Gibson, Sundara Ramaprabhu, Tomasz Pańczyk, Alberto Bianco, Giorgia Pastorin	57
12	Zygote serine decreased uptake from the fertilization medium is associated with implantation and pregnancy 2014 ·Journal of Assisted Reproduction and Genetics ·(unknown), (unknown), Einat Aizenman, Dan Gibson, Yoel Shufaro	8
13	On the Stability of Pt^IV Pro‐Drugs with Haloacetato Ligands in the Axial Positions 2014 ·Chemistry - A European Journal ·Ezequiel Wexselblatt, Raji Raveendran, (unknown), Aviva Ezra, Eylon Yavin, Dan Gibson	47
14	Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands 2014 ·Journal of Inorganic Biochemistry ·Vojtěch Novohradský, Lenka Zerzánková, Jana Štěpánková, Oldřich Vrána, Raji Raveendran, Dan Gibson, Jana Kašpárková, Viktor Brabec	70
15	Platinum(IV) Prodrugs with Haloacetato Ligands in the Axial Positions can Undergo Hydrolysis under Biologically Relevant Conditions 2013 ·Angewandte Chemie International Edition ·Ezequiel Wexselblatt, Eylon Yavin, Dan Gibson	78
16	Peculiar mechanistic and structural features of the carboplatin–cytochrome c system revealed by ESI-MS analysis 2008 ·JBIC Journal of Biological Inorganic Chemistry ·Chiara Gabbiani, Angela Casini, Guido Mastrobuoni, (unknown), (unknown), Giuseppe Pieraccini, Gloriano Moneti, Luigi Messori, Dan Gibson	34
17	DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)] 2007 ·Biochemical Pharmacology ·Viktor Brabec, (unknown), (unknown), Hana Kostrhunová, Olga Nováková, Yousef Najajreh, Dan Gibson, Jana Kašpárková	11
18	Mass spectrometric studies of the formation and reactivity of trans ‐[PtCl ₂ (Am)(piperidinopiperidine)] · HCl complexes with ubiquitin 2005 ·Rapid Communications in Mass Spectrometry ·(unknown), Dan Gibson	9
19	N-Alkyl colchiceineamides: their inhibition of GTP or taxol-induced assembly of tubulin 1988 ·Biochemical Pharmacology ·Israel Ringel, (unknown), Wilfredo Mellado, Avner Ramu, Dan Gibson, Jehoshua Katzhendler	9
20	Structure of the gas-phase ion C6H5+ 1980 ·International Journal of Mass Spectrometry and Ion Physics ·Chava Lifshitz, Dan Gibson, K. Levsen	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact